Peripheral T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Peripheral T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma [Phase 2, Phase 3]
This document reports on an ongoing Phase 2/Phase 3 clinical trial evaluating cidabenamine plus azacitidine to prevent post-transplant progr…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma [Phase 1, Phase 2]
Clinical trial evaluating HH2853 for relapsed/refractory peripheral T-cell lymphoma is currently recruiting in Phase 1 and Phase 2.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Evaluate the Safety and Clinical Activity of HH2853 [Phase 1, Phase 2]
The trial update indicates HH2853 is being studied in Phase 1/Phase 2 across follicular lymphoma, epithelioid sarcoma, peripheral T-cell lym…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL [Phase 2]
Phase 2 clinical trial evaluating Zeprumetostat and Azacitidine in combination with Lipo-MIT for relapsed/refractory peripheral T-cell lymph…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL [Phase 2]
A randomized Phase II trial is comparing oral azacitidine plus romidepsin against investigator's choice in peripheral T-cell lymphoma and is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR
ClinicalTrials.gov entry describes a recruiting study from Shanghai General Hospital investigating stratified therapy after complete respons…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating SHR2554 as maintenance therapy for Peripheral T-cell lymphoma, with recruitm…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma [Phase 3]
A Phase III randomized, double-blind multicenter study evaluating XNW5004 tablets in patients with relapsed or refractory peripheral T-cell …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma [Phase 3]
Phase 3 study of chidamide (SHR2554) for relapsed/refractory peripheral T-cell lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma [Phase 1, Phase 2]
Clinical trial update on a Phase 1/Phase 2 study of golidocitinib combined with mitoxantrone hydrochloride liposome or chidamide for relapse…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)
A prospective, multicenter cohort study evaluating allogeneic versus autologous hematopoietic stem cell transplantation for peripheral T-cel…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies [Phase 1, Phase 2]
A Phase 1/2 study is evaluating CCS1477 (Inobrodib) in multiple hematologic malignancies and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL) [Phase 1, Phase 2]
This clinical trial update outlines a Phase 1/Phase 2 study evaluating the combination of liposomal mitoxantrone hydrochloride and Enlonstob…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Amping up With PemJAK [Phase 2]
A Phase 2 clinical trial of PemJAK for multiple lymphoma subtypes is currently recruiting, including non-Hodgkin lymphoma and Hodgkin lympho…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Golidocitinib Combined With GemOx in RR PTCL [Phase 2]
Phase 2 clinical trial update for golidocitinib in combination with GemOx for relapsed/refractory peripheral T-cell lymphoma; the trial is n…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Linperlisib Combined With Chidamide in Patients With PTCL [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of linperlisib with chidamide in patients with peripheral T-cell lymphoma is currently…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial (NCT02223208) evaluates Ro plus CHOEP as first-line therapy before hematopoietic stem cell transplantation in you…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma [EARLY_Phase 1]
A Phase 1 trial assessing safety and preliminary efficacy of anti-EBV autologous TCR-T cell therapy in relapsed/refractory EBV-positive lymp…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19) [Phase 3]
A Phase 3 multinational trial evaluating golidocitinib versus investigator's choice in relapsed/refractory peripheral T-cell lymphoma is cur…
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL [Phase 3]
A Phase 3 trial is evaluating belinostat or pralatrexate in combination with CHOP versus CHOP alone for peripheral T cell lymphoma. Recruitm…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Combination Therapy With Tazemetostat in Relapsed and Refractory Peripheral T-cell Lymphoma [Phase 1, Phase 2]
Clinical trial update describing Phase 1 and Phase 2 evaluation of tazemetostat in relapsed and refractory peripheral T-cell lymphoma, with …
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma [Phase 2]
This is a Phase 2 clinical trial update for a CD30-targeted CAR T-cell therapy for relapsed/refractory CD30-positive peripheral T-cell lymph…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of ST-001 nanoFenretinide for relapsed/refractory T-cell non-Hodgkin lymphoma is currently recruiting, targeting multiple T-ce…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype [Phase 3]
A Phase 3 trial evaluating Tucidinostat in combination with CHOP for newly diagnosed peripheral T-cell lymphoma with follicular helper T-cel…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of pembrolizumab and olaparib for relapsed or refractory peripheral T-cell lymphoma, cur…